88 ANB032, a novel BTLA agonist monoclonal antibody, inhibits T cell proliferation, reduces inflammatory cytokines, and down modulates BTLA expression on circulating T and B cells
- Resource Type
- Abstract
- Source
- In
Journal of Investigative Dermatology November 2023 143(11) Supplement:S347-S347 - Subject
- Language
- ISSN
- 0022-202X